3. autosomal recessive disease deficiency of glutaryl-CoA dehydrogenase 1 : 100 000 GCDH gene chromosome 19p13.2.

Slides:



Advertisements
Similar presentations
Mass Screening Using Tandem Mass Spectrometry: Friend or Foe?
Advertisements

Alterations in Metabolic Status Jan Bazner-Chandler RN, MSN, CNS, CPNP.
Health and Wellness for all Arizonans azdhs.gov Dr Bradley Golner, MD Phoenix Pediatrics Az EHDI Chapter Champion.
The Clinic for Special Children Where compassion, care, and bioinformatics result in cutting edge translational medicine.
Nicola Longo MD PhD FACMG Professor and Chief Division of Medical Genetics, Department of Pediatrics, University of Utah, Salt Lake City Study funding.
Medical Mystery Patient X. Symptoms 0 Patient’s Symptoms: 0 Possible Diseases/Disorders: 0 Final Diagnosis:
Part A/Module A1/Session 4 Part A: Module A1 Session 4 Comprehensive Care for People Living with HIV/AIDS (PLHA)
AMCHP 2005 Conference Newborn Screening in Maryland The Maryland Program Informed Consent Informational Materials Linkage to Services Challenges of Working.
CF Related Diabetes ADEU November Cystic Fibrosis Genetic disorder Exocrine pancreas dysfunction Autosomal recessive inheritance Several identified.
Krabbe Disease: A Case Report Nicole Keller D.O., Alison Chase D.O. Department of Pediatrics, Advocate Hope Children’s Hospital Krabbe Disease: A Case.
Cystic Fibrosis Gina Brandl, RN BSN Nursing Instructor, Pediatrics.
Genetic screening.
Melissa Ewerth Graduate Adapted Physical Education, WCU.
Chapter 11 Newborn Screening. Introduction Newborns can be screened for an increasing variety of conditions on the principle that early detection can.
ANNE LEHMAN 8/29/13 MAPLE SYRUP URINE DISEASE. BACKGROUND Autosomal recessive metabolic disorder Mutation in genes encoding Branched-chain α- ketoacid.
1 KEEP YOUR EYES OPEN! Untreated co-morbidities in adults with Epilepsy and Learning Disability Authors; Flinton L, Pashley S, Lewington E.
Issues in Genetic Testing: Real versus Not-so-Real Roberta A Pagon, MD Principal Investigator, GeneTests Professor, Pediatrics University of Washington.
- Genetic Testing - - Genetic Counseling - - Genetic Therapy - By: Austin Justin Amanda Brie.
Genetic testing: Past, present, future
Biotinidase deficiency: clinical presentation, treatment and screening
What is Genetic Testing? And what is its value? Sherri J. Bale, Ph.D., FACMG President and Clinical Director GeneDx.
Supplements and Co-factors in the Treatment of Metabolic Disorders Lynne A. Wolfe, MS, CRNP, BC Metabolic Nurse Practitioner Children’s Hospital of Pittsburgh.
MAPLE SYRUP URINE DISEASE (MSUD) IS A METABOLISM DISORDER PASSED DOWN THROUGH FAMILIES IN WHICH THE BODY CANNOT BREAK DOWN CERTAIN PARTS OF PROTEINS. URINE.
Amino acid Profiling Research Center for Genetic Engineering and Biotechnology “Georgi D. Efremov”, MASA What is amino acid profiling? Amino acids are.
Your Family Health History
Mutations.
Pregnancy & Newborn Screening Developments Medium Chain Acyl CoA Dehydrogenase Deficiency (MCADD)
Alport Syndrome Genetics and Diagnosis Martin Gregory, MD, PhD Professor of Medicine University of Utah Nothing to disclose.
Continuity Clinic The Exciting, Emotional and often Misunderstood World of.
Unit 5 – Public Health Chronic Diseases
9/7/2015Mahia Samaha Alkony1 Genetics By: Mrs. Mahdiah Samaha Alkony.
Inborn Errors of Metabolism Monica Egan. Video Links Part 1: – xWwY&feature=plcphttp://
Copyright © The McGraw-Hill Companies, Inc. Permission required for reproduction or display Chapter 20 Genetic Testing, Genetic Counseling, and Gene.
Simultaneous occurrence of two chromosomal abnormalities, independent of each other, in a 2 year old female patient. Jennifer Bell.
Case Study #1 You are an Army officer during the Korean War, and are in charge of a group of soldiers preparing to deploy from Fort Dix, New Jersey. In.
Meiosis &Genetic Inherited Diseases. You are a member of a genetic counselor team works in a hospital to present accurate information to parents about.
What is sickle cell disease? Sickle cell disease is a disorder that affects.
PKU- Cell Storage Disorder!! By: Brianna Hopkins.
Presenters: PICU/AO1 UNIT Moderators: Dr Somwe Dr Mwenechanya
Ann Jolly1 Screening “...the identification of unrecognized disease or defect by the application of tests, examinations or other procedures...” “...sort.
Understanding Genetic Testing
MAJOR EVENTS AND EVOLUTION IN CYSTIC FIBROSIS PATIENTS Author: Alexandra Martin Coordinator: Dr. Reka Borka Balas University of Medicine and Pharmacy Târgu-
Cystic Fibrosis.
Maple Syrup Urine Disease (MSUD)
The Nuts and Bolts of The Energy Pathway Darius J. Adams, M.D. Genetics and Metabolism.
Genetic testing: Past, present, future. What is Genetic Testing? A genetic test is the analysis of human DNA, RNA, chromosomes, proteins, or metabolites.
NEWBORN SCREENING Greg Enns, MB, ChB, FAAP Professor of Pediatrics
CAT 4: How to Read a Prognosis Article Maribeth Chitkara, MD Rachel Boykan, MD.
Biomarker introduction Annemieke Aartsma-Rus November
Many hundred disorders resulting from this type of inheritance are known An affected individual is homozygous for the abnormal gene, having inherited an.
Bruno Sopko. Genetics Biochemistry Clinical medicine.
 Disclaimer:  The statements in this presentation are those of the author and not of Affymetrix.  CytoScan has not been cleared or evaluated by the.
Genetic Diseases. Analytical methods for the identification of genetic disease play an important part in the pediatric clinical chemistry laboratory.
TB in Yorkshire and the Humber Dr Simon Padfield 14 th Sept 2007.
© 2007 McGraw-Hill Higher Education. All rights reserved. Chapter 2 Genetics: You and Your Family Health History.
Barth Syndrome (BTHS) By: Glorimar Vega.
MCADD, caused by mutation in the ACADM gene is the most common disorder of fatty acid  - oxidation. Treatment is very successfully if started before symptoms.
1 Copyright © 2012 by Mosby, an imprint of Elsevier Inc. Copyright © 2008 by Mosby, Inc., an affiliate of Elsevier Inc. Chapter 11 Genomics in Public Health.
MANGEMENT OF GLUCOSE-6-PHOSPHATE DEHYDROGENASE DEFICIENCY
Hyperphenylalaninaemia
Chapter 19 Inborn Errors of Metabolism
What does this protein make up or do?
Hunter Syndrome: Why We Need to Diagnose and Treat Early
دكتر سوسن فقيه ايماني متخصص كودكان (عضوتيم باليني PKU استان اصفهان)
argininosuccinate lyase What does this protein make up or do?
Name of the disorder.
Name of the disorder.
PROGERIA By: Monica Cruz.
Clinical Genomics in Inflammatory Bowel Disease
Presentation transcript:

3

autosomal recessive disease deficiency of glutaryl-CoA dehydrogenase 1 : GCDH gene chromosome 19p13.2

#1 The accurate diagnosis of GA-I has important practical implications when devising treatment plans and giving appropriate information to children and their families. #2 For mass newborn screening for glutaric aciduria type I determination of C5DC in DBS by MS/MS should be used

High excretors: Amish Lumbee Irish Travellers Low excretors: Oji-Cree natives

#3 In a cohort with a high disease incidence due to a single common GCDH mutation and a low excretor phenotype, DNA based methods should be considered for newborn screening. The use of MS/MS-based screening in such populations will likely lead to false negative results

# 4: For the confirmation of a positive newborn screening result, a specific diagnostic workup is required, including a quantitative analysis of GA and 3-OH-GA

#5 …….GCDH gene mutation analysis, and/or enzyme analysis #6 Metabolic treatment ……. by an interdisciplinary team….. (metabolic pediatrian, dietetist, nurse) + parents and patients training #7 low lysine diet #8. L-Carnitine #9. Emergency treatment

#9. Emergency treatment should start without delay and should be performed aggressively during febrile illness, surgery and immunization within the vulnerable period for acute encephalopathic crises (up to age 6 years) #10 > 6 years …..

#11 neurological evaluation #12 Baclofene and/or diazepanes in case of dystomnia #13 Antiepileptic drugs ……. VALPROATE

#15. Glutaric aciduria type I should be excluded in children with suspected shaken baby syndrome #14. Children with subdural haemorrhage and/or bitemporal arachnoid cysts should be investigated for glutaric aciduria GA I ?

#16 neurosorgical interventions - pediatric neurosurgeon #17 monitoring in any age, in case of new complications #18 Urine analysis of GA and 3-OH-GA is not informative for therapy monitoring

# 19 Amino acids monitoring # 20 Carnitine monitoring (avoid secondary depletion) #21 Neuroradiologic investigation

Děkuji za pozornost